MENU
+Compare
NTRB
Stock ticker: NASDAQ
AS OF
Aug 8 closing price
Price
$7.17
Change
+$0.04 (+0.56%)
Capitalization
79.8M

NTRB Nutriband Forecast, Technical & Fundamental Analysis

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products... Show more

NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NTRB with price predictions
Aug 08, 2025

NTRB in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 30, 2025

NTRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where NTRB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRB advanced for three days, in of 201 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NTRB moved out of overbought territory on July 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRB as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NTRB turned negative on July 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

NTRB moved below its 50-day moving average on July 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NTRB crossed bearishly below the 50-day moving average on August 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NTRB entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NTRB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.649) is normal, around the industry mean (18.712). P/E Ratio (0.000) is within average values for comparable stocks, (55.605). NTRB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.011). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (33.223) is also within normal values, averaging (287.742).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NTRB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTRB is expected to report earnings to fall 66.00% to -17 cents per share on October 01

Nutriband NTRB Stock Earnings Reports
Q3'25
Est.
$-0.17
Q1'25
Missed
by $0.38
Q1'23
Missed
by $0.17
Q4'22
Missed
by $0.03
Q3'22
Est.
$-0.12
The last earnings report on May 02 showed earnings per share of -50 cents, missing the estimate of -11 cents. With 3.16M shares outstanding, the current market capitalization sits at 79.80M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
121 South Orange Avenue
Phone
+1 407 377-6695
Employees
13
Web
https://www.nutriband.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMYSF1.14N/A
N/A
Namsys, Inc.
GBLBF85.08N/A
N/A
Groupe Bruxelles Lambert SA
ACAT0.05N/A
N/A
Acasia Technology, Inc.
BGAOF9.98N/A
N/A
Proximus Group

NTRB and Stocks

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
+0.56%
VRAX - NTRB
31%
Poorly correlated
-0.78%
ABSI - NTRB
28%
Poorly correlated
-2.41%
SYRE - NTRB
27%
Poorly correlated
-0.52%
STOK - NTRB
27%
Poorly correlated
-1.13%
DNLI - NTRB
26%
Poorly correlated
-1.90%
More